Mazyar Yazdani

  • Senior Scientist; PhD

Education

  • 2009-2014: PhD in Integrative Biology - Toxicology, Department of Biosciences, University of Oslo, Norway

Thesis: In vitro, in ovo and in vivo models for cytotoxicity, oxidative stress, neurotoxicity and DNA damage

Committee: Ketil Hylland, Ragnhild Paulsen & Tor Gjøen   (Collaborator: Gunnar Brunborg, Norwegian Institute of Public Health)

Affiliation

– Associated member of:

Research Summary

Dr. Yazdani, a toxicologist, began his research career by studying the mechanisms of action of hazardous substances, with emphasis on oxidative stress induction and in vitro (cell culture) method development. He later linked the role of oxidative stress to pathophysiology of dry eye disease and treatment of corneal epithelial (limbal) stem cell deficiency. Currently, as a core member of the Metabolomics & Metabolic Molecular Biology group, he is investigating the role of metabolic changes in health and disease. The main goal is to better understand the mechanisms underlying disease development using mass spectrometry-based metabolomics and lipidomics. Apart from these, Mazyar has always had a keen interest in biological role and effects of oxygen. He is interested in both empirical and conceptual research (Read more here). 

Selected projects

Mazyar is involved in several projects (on eye, brain, blood, etc.), but his main fields of interest are ophthalmology and neurology. Some examples:

Dry eye disease (e.g., Yazdani et al 2021a), Kearns–Sayre syndrome (e.g., Salvador et al 2023), Pyridoxine-dependent epilepsy (e.g., Böhm et al 2022) & Neurotoxicity (e.g., Mathisen et al 2013).

Highlights

Current PhD students

  • Fredrik Fineide, Since 2024, Optimization of current dry eye disease treatment regimens through artificial intelligence
  • Morten Gundersen, Since 2023, Metabolomic profile in tear film samples of patients with or without dry eye disease before and after cataract surgery
  • Madhavi bhandari, Since 2021, Lacritin-incorporated nanoparticles as new and improved treatment of dry eye disease

Work Experience

  • 2021-to date: Metabolomics Group, Oslo University Hospital (OUS) - Rikshospitalet, Oslo
  • 2017-2020: Regenerative Medicine Group, Oslo University Hospital (OUS) - Ullevål Sykehus, Oslo
  • 2016: Health Effects Group, Norwegian Institute for Air Research (NILU), Kjeller + Norwegian Dry Eye Clinic (TØK), Oslo
  • 2015: Toxicology Group and Ecotoxicology Group, Norwegian Food Safety Authority (Mattilsynet), Ås
  • 2009-2014: Toxicology Group, University of Oslo (UiO), Oslo

Links

NB: Visit our NEWS PAGE for the latest updates and the Galleries (Links: 1, 2, 3 & 4) for social events!

 

Publications 2024

Ghannoum M, Waters PJ, Hovda KE, Choquette G, Elgstøen KBP, Nygaard I, Rootwelt H, Hickey D, Yazdani M, Bourque DK (2024)
Can endogenous ethylene glycol production occur in humans? A detailed investigation of adult monozygotic twin sisters
Clin Toxicol (Phila), 62 (11), 698-706
DOI 10.1080/15563650.2024.2401076, PubMed 39327950

Gundersen M, Jensen P, Nilsen C, Yazdani M, Utheim Ø, Sandås EM, Rootwelt H, Gundersen KG, Elgstøen KBP (2024)
Method Development for Omics Analyses using Schirmer Strips
Curr Eye Res, 49 (7), 708-716
DOI 10.1080/02713683.2024.2335271, PubMed 38567868

Rolić T, Yazdani M, Mandić S, Distante S (2024)
Iron Metabolism, Calcium, Magnesium and Trace Elements: A Review
Biol Trace Elem Res (in press)
DOI 10.1007/s12011-024-04289-z, PubMed 38969940

Yazdani M (2024)
Cellular and Molecular Responses to Mitochondrial DNA Deletions in Kearns-Sayre Syndrome: Some Underlying Mechanisms
Mol Neurobiol, 61 (8), 5665-5679
DOI 10.1007/s12035-024-03938-7, PubMed 38224444

Publications 2023

Salvador CL, Oppebøen M, Vassli AØ, Pfeiffer HCV, Varhaug KN, Elgstøen KBP, Yazdani M (2023)
Increased Sphingomyelin and Free Sialic Acid in Cerebrospinal Fluid of Kearns-Sayre Syndrome: New Findings Using Untargeted Metabolomics
Pediatr Neurol, 143, 68-76
DOI 10.1016/j.pediatrneurol.2023.02.016, PubMed 37018879

Yazdani M (2023)
Tear film lipid layer and corneal oxygenation: a new function?
Eye (Lond), 37 (17), 3534-3541
DOI 10.1038/s41433-023-02557-1, PubMed 37138094

Publications 2022

Bhandari M, Nguyen S, Yazdani M, Utheim TP, Hagesaether E (2022)
The Therapeutic Benefits of Nanoencapsulation in Drug Delivery to the Anterior Segment of the Eye: A Systematic Review
Front Pharmacol, 13, 903519
DOI 10.3389/fphar.2022.903519, PubMed 35645827

Böhm HO, Yazdani M, Sandås EM, Østeby Vassli A, Kristensen E, Rootwelt H, Skogvold HB, Brodtkorb E, Elgstøen KBP (2022)
Global Metabolomics Discovers Two Novel Biomarkers in Pyridoxine-Dependent Epilepsy Caused by ALDH7A1 Deficiency
Int J Mol Sci, 23 (24)
DOI 10.3390/ijms232416061, PubMed 36555701

Yazdani M (2022)
Uncontrolled Oxygen Levels in Cultures of Retinal Pigment Epithelium: Have We Missed the Obvious?
Curr Eye Res, 47 (5), 651-660
DOI 10.1080/02713683.2022.2050264, PubMed 35243933

Yazdani M, Distante S, Mørkrid L, Ulvik RJ, Bolann BJ (2022)
Bloodlettings in Hemochromatosis Result in Increased Blood Lead (Pb) Concentrations
Biol Trace Elem Res, 201 (7), 3193-3201
DOI 10.1007/s12011-022-03424-y, PubMed 36168081

Publications 2021

Bendiksen Skogvold H, Yazdani M, Sandås EM, Østeby Vassli A, Kristensen E, Haarr D, Rootwelt H, Elgstøen KBP (2021)
A pioneer study on human 3-nitropropionic acid intoxication: Contributions from metabolomics
J Appl Toxicol, 42 (5), 818-829
DOI 10.1002/jat.4259, PubMed 34725838

Yazdani M, Elgstøen KBP (2021)
Is oxidative stress an overlooked player in pyridoxine-dependent epilepsy? A focused review
Seizure, 91, 369-373
DOI 10.1016/j.seizure.2021.07.014, PubMed 34298455

Yazdani M, Elgstøen KBP, Utheim TP (2021)
Eye Make-up Products and Dry Eye Disease: A Mini Review
Curr Eye Res, 47 (1), 1-11
DOI 10.1080/02713683.2021.1966476, PubMed 34365876

Yazdani M, Fiskådal J, Chen X, Utheim ØA, Ræder S, Vitelli V, Utheim TP (2021)
Tear Film Break-Up Time and Dry Eye Disease Severity in a Large Norwegian Cohort
J Clin Med, 10 (4)
DOI 10.3390/jcm10040884, PubMed 33671667

Publications 2020

Gautvik KM, Günther CC, Prijatelj V, Medina-Gomez C, Shevroja E, Rad LH, Yazdani M, Lindalen E, Valland H, Gautvik VT, Olstad OK, Holden M, Rivadeneira F, Utheim TP, Reppe S (2020)
Distinct Subsets of Noncoding RNAs Are Strongly Associated With BMD and Fracture, Studied in Weight-Bearing and Non-Weight-Bearing Human Bone
J Bone Miner Res, 35 (6), 1065-1076
DOI 10.1002/jbmr.3974, PubMed 32017184

Tashbayev B, Utheim TP, Utheim ØA, Ræder S, Jensen JL, Yazdani M, Lagali N, Vitelli V, Dartt DA, Chen X (2020)
Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease
Sci Rep, 10 (1), 5542
DOI 10.1038/s41598-020-62583-x, PubMed 32218518

Tashbayev B, Yazdani M, Arita R, Fineide F, Utheim TP (2020)
Intense pulsed light treatment in meibomian gland dysfunction: A concise review
Ocul Surf, 18 (4), 583-594
DOI 10.1016/j.jtos.2020.06.002, PubMed 32629039

Yazdani M, Shahdadfar A, Reppe S, Sapkota D, Vallenari EM, Lako M, Connon CJ, Figueiredo FC, Utheim TP (2020)
Response of human oral mucosal epithelial cells to different storage temperatures: A structural and transcriptional study
PLoS One, 15 (12), e0243914
DOI 10.1371/journal.pone.0243914, PubMed 33326470

Publications 2019

Yazdani M, Chen X, Tashbayev B, Utheim ØA, Ræder S, Hua Y, Eidet JR, Stojanovic A, Dartt DA, Utheim TP (2019)
Evaluation of the Ocular Surface Disease Index Questionnaire as a Discriminative Test for Clinical Findings in Dry Eye Disease Patients
Curr Eye Res, 44 (9), 941-947
DOI 10.1080/02713683.2019.1604972, PubMed 30955380

Yazdani M, Elgstøen KBP, Rootwelt H, Shahdadfar A, Utheim ØA, Utheim TP (2019)
Tear Metabolomics in Dry Eye Disease: A Review
Int J Mol Sci, 20 (15)
DOI 10.3390/ijms20153755, PubMed 31374809

Yazdani M, Shahdadfar A, Jackson CJ, Utheim TP (2019)
Hyaluronan-Based Hydrogel Scaffolds for Limbal Stem Cell Transplantation: A Review
Cells, 8 (3)
DOI 10.3390/cells8030245, PubMed 30875861

Yazdani M, Shahdadfar A, Jackson CJ, Utheim TP (2019)
A Hyaluronan Hydrogel Scaffold for Culture of Human Oral Mucosal Epithelial Cells in Limbal Stem-Cell Therapy
Bioengineering (Basel), 6 (4)
DOI 10.3390/bioengineering6040097, PubMed 31652804

Publications 2018

Yazdani M (2018)
Comparative toxicity of selected PAHs in rainbow trout hepatocytes: genotoxicity, oxidative stress and cytotoxicity
Drug Chem Toxicol, 43 (1), 71-78
DOI 10.1080/01480545.2018.1497054, PubMed 30246564

Yazdani M, Chen X, Tashbayev B, Utheim ØA, Ræder S, Lagali N, Stojanovic A, Dartt DA, Utheim TP (2018)
Tear Production Levels and Dry Eye Disease Severity in a Large Norwegian Cohort
Curr Eye Res, 43 (12), 1465-1470
DOI 10.1080/02713683.2018.1514055, PubMed 30183390

Publications 2016

Gábelová A, El Yamani N, Alonso TI, Buliaková B, Srančíková A, Bábelová A, Pran ER, Fjellsbø LM, Elje E, Yazdani M, Silva MJ, Dušinská M (2016)
Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles
Mutagenesis, 32 (1), 193-202
DOI 10.1093/mutage/gew045, PubMed 27658822

Yazdani M (2016)
Technical aspects of oxygen level regulation in primary cell cultures: A review
Interdiscip Toxicol, 9 (3-4), 85-89
DOI 10.1515/intox-2016-0011, PubMed 28652851

Yazdani M, Andresen AM, Gjøen T (2016)
Short-term effect of bisphenol-a on oxidative stress responses in Atlantic salmon kidney cell line: a transcriptional study
Toxicol Mech Methods, 26 (4), 295-300
DOI 10.1080/15376516.2016.1177864, PubMed 27117342

Yazdani M, Hylland K (2016)
A Kinetic Study of Reactive Oxygen Species in Rainbow Trout Hepatocytes by Fluorometry
J Environ Pathol Toxicol Oncol, 35 (4), 291-297
DOI 10.1615/JEnvironPatholToxicolOncol.2016016184, PubMed 27992310

Publications 2015

Yazdani M (2015)
Concerns in the application of fluorescent probes DCDHF-DA, DHR 123 and DHE to measure reactive oxygen species in vitro
Toxicol In Vitro, 30 (1 Pt B), 578-82
DOI 10.1016/j.tiv.2015.08.010, PubMed 26318276

Publications 2014

Yazdani M, Paulsen RE, Gjøen T, Hylland K (2014)
Reactive oxygen species and cytotoxicity in rainbow trout hepatocytes: effects of medium and incubation time
Bull Environ Contam Toxicol, 94 (2), 193-8
DOI 10.1007/s00128-014-1433-0, PubMed 25432295

Publications 2013

Mathisen GH, Yazdani M, Rakkestad KE, Aden PK, Bodin J, Samuelsen M, Nygaard UC, Goverud IL, Gaarder M, Løberg EM, Bølling AK, Becher R, Paulsen RE (2013)
Prenatal exposure to bisphenol A interferes with the development of cerebellar granule neurons in mice and chicken
Int J Dev Neurosci, 31 (8), 762-9
DOI 10.1016/j.ijdevneu.2013.09.009, PubMed 24091367

Publications 2011

Ellesat KS, Yazdani M, Holth TF, Hylland K (2011)
Species-dependent sensitivity to contaminants: an approach using primary hepatocyte cultures with three marine fish species
Mar Environ Res, 72 (4), 216-24
DOI 10.1016/j.marenvres.2011.09.003, PubMed 21963059

Yap CK, Yazdani M, Abdullah F, Tan SG (2011)
Is the high Cu tolerance of Trichoderma atroviride isolated from the Cu-polluted sediment due to adaptation? An in vitro toxicological study
Journal of Sains Malaysiana , 40 (2), 119-124
PublikaID 362

Publications 2010

Yap CK, Fitri M, Yazdani M, Tan SG (2010)
Effects of the metal contaminated soils on the accumulation of heavy metals in the different parts of Centella asiatica: A laboratory study
Journal of Sains Malaysiana, 39 (3), 347-352
PublikaID 360

Yazdani M, Yap CK, Abdullah F, Tan SG (2010)
An in vitro study on the adsorption, absorption and uptake capacity of Zn by using the bioremediator Trichoderma atroviride
EnvironmentAsia, 3 (1), 53-59
PublikaID 361

Publications 2009

Yap CK, Yazdani M (2009)
The identification of point sources in a river receiving industrial metal effluents at the Serdang industrial area, Selangor
Sustainability Science and Management, 4 (2), 18-26
PublikaID 358

Yazdani M, Yap CK, Abdullah F, Tan SG (2009)
Trichoderma atroviride as a bioremediator of Cu pollution: An in vitro study
Toxicological & Environmental Chemistry , 91 (7), 1305-1314
DOI 10.1080/02772240802616510, PublikaID 359